Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Sleep-disordered breathing in multiple sclerosis.
A prospective observational safety study on MF59(®) adjuvanted cell culture-derived vaccine, Celtura(®) during the A/H1N1 (2009) influenza pandemic.
IgM antibody identifies good candidates for natalizumab
Effects of cannabis on cognition in patients with MS: A psychometric and MRI study.
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation.
Could Intrathymic Injection of Myelin Basic Protein Suppress Inflammatory Response After Co-culture of T Lymphocytes and BV-2 Microglia Cells?
Effects of dual-task balance training on postural performance in patients with Multiple Sclerosis: A double-blind, randomized controlled pilot trial.
Topographical and Biological Evidence Revealed FTY720-Mediated Anergy-Polarization of Mouse Bone Marrow-Derived Dendritic Cells In Vitro.
In multiple sclerosis oligoclonal bands connect to peripheral B cell responses.
Please mind the gap: axonal transport deficits in multiple sclerosis neurodegeneration.
Cbl-b-deficient mice express alterations in trafficking-related molecules but retain sensitivity to the multiple sclerosis therapeutic agent, FTY720.
Vitamin D-binding protein and vitamin D status of black Americans and white Americans.
Substance Name: Phenytoin
Complement activation in multiple sclerosis plaques: an immunohistochemical analysis.
Exome sequencing in single cells from the cerebrospinal fluid in multiple sclerosis.
Microparticle Platform
Implication of perturbed axoglial apparatus in early pediatric multiple sclerosis.
A pilot randomised controlled trial of an Internet-based cognitive behavioural therapy self-management programme (MS Invigor8) for multiple sclerosis fatigue.
Surgical management of malignant cerebral edema secondary to immune reconstitution inflammatory syndrome from natalizumab-associated progressive multifocal encephalopathy.
Health-related quality of life and disease-modifying treatment behaviour in relapsing-remitting multiple sclerosis - a multicentre cohort study.
Suppression of Experimental Autoimmune Optic Neuritis by the Novel Agent Fingolimod.
Disease exacerbation of multiple sclerosis is characterized by loss of terminally differentiated autoregulatory CD8+ T cells.
A Study of the Safety and Tolerability of MEDI-551 in Scleroderma
Intermittent Atrioventricular Block following Fingolimod Initiation.
Sphingosine 1-phosphate (S1P): Physiology and the effects of S1P receptor modulation.

Pages